Regeneron Pharmaceuticals | REGN - Passività Correnti





Passività Correnti Cambiamento Data
AbbVie USD 41.64B 458M 2026-06
Agenus USD 231.82M 17.42M 2026-06
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 25.5B 547M 2026-06
Astellas Pharma JPY 1.23T 16.36B 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Eli Lilly USD 47B 745M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 55.46B 562M 2026-09
Kyowa Hakko Kirin JPY 150.28B 32.11B 2026-09
Merck USD 27.73B 786M 2026-06
Moderna USD 2.53B 139M 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novartis USD 31.75B 374M 2026-06
Novartis USD 32.52B 1.15B 2026-09
Pfizer USD 32.65B 1.7B 2026-06
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 31.93B 1.92B 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06